Table 4 The average incidence of TORCH infection with a heterogeneous aetiology
| Â | No disease N (%) 60 (28.6%) | Infected with mono agents N (%) 97 (46.2%) | Infected with two agents N (%) 45 (21.4%) | Infected with three agents N (%) 8 (3.8%) | Total N (%) 210 (100%) |
|---|---|---|---|---|---|
Age (years) | |||||
 ≤ 25 years | 30 (50.0%) | 71 (73.2%) | 19 (42.2%) | 8 (100%) | 128 (61%) |
 > 25 years | 30 (50.0%) | 26 (26.8%) | 26 (57.8%) | 0 (0.0%) | 82 (39%) |
 Z test | 1.9 | 6 | 1.26 | 3.5 |  |
 P-value | 0.06 | < 0.001 | 0.21 | < 0.001 |  |
Mono infection | The studied women | ||
|---|---|---|---|
N = 210 | |||
N = 97 | % from its category | % from the total group | |
 Toxoplasma | 54 | 55.70% | 25.70% |
 Rubella | 10 | 4.80% | 10.30% |
 CMV | 22 | 10.50% | 22.70% |
 Herpes simplex | 11 | 5.20% | 11.30% |
Double infection | N = 45 |  |  |
 Toxoplasma + Rubella | 12 | 26.70% | 5.70% |
 Toxoplasma + Herpes simplex | 4 | 8.90% | 1.90% |
 Rubella + CMV | 29 | 64.40% | 13.80% |
Triple infection | N = 8 |  |  |
 Toxoplasmosis + Rubella + CMV | 8 | 100% | 3.80% |